{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:37:59Z","timestamp":1777610279237,"version":"3.51.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,1,30]],"date-time":"2009-01-30T00:00:00Z","timestamp":1233273600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1007\/s00280-009-0932-x","type":"journal-article","created":{"date-parts":[[2009,1,31]],"date-time":"2009-01-31T16:00:03Z","timestamp":1233417603000},"page":"811-827","source":"Crossref","is-referenced-by-count":85,"title":["Doxorubicin-induced mitochondrial dysfunction is secondary to nuclear p53 activation in H9c2 cardiomyoblasts"],"prefix":"10.1007","volume":"64","author":[{"given":"Vilma A.","family":"Sard\u00e3o","sequence":"first","affiliation":[]},{"given":"Paulo J.","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Jon","family":"Holy","sequence":"additional","affiliation":[]},{"given":"Catarina R.","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Kendall B.","family":"Wallace","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2009,1,30]]},"reference":[{"key":"932_CR1","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1016\/S0021-9258(17)35747-2","volume":"261","author":"JH Doroshow","year":"1986","unstructured":"Doroshow JH, Davies KJ (1986) Redox cycling of anthracyclines by cardiac mitochondria. II. Formation of superoxide anion, hydrogen peroxide, and hydroxyl radical. J Biol Chem 261:3068\u20133074","journal-title":"J Biol Chem"},{"key":"932_CR2","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1016\/S0021-9258(17)35746-0","volume":"261","author":"KJ Davies","year":"1986","unstructured":"Davies KJ, Doroshow JH (1986) Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase. J Biol Chem 261:3060\u20133067","journal-title":"J Biol Chem"},{"key":"932_CR3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1034\/j.1600-0773.2003.930301.x","volume":"93","author":"KB Wallace","year":"2003","unstructured":"Wallace KB (2003) Doxorubicin-induced cardiac mitochondrionopathy. Pharmacol Toxicol 93:105\u2013115","journal-title":"Pharmacol Toxicol"},{"key":"932_CR4","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/0006-2952(83)90593-2","volume":"32","author":"E Goormaghtigh","year":"1983","unstructured":"Goormaghtigh E, Pollakis G, Ruysschaert JM (1983) Mitochondrial membrane modifications induced by adriamycin-mediated electron transport. Biochem Pharmacol 32:889\u2013893","journal-title":"Biochem Pharmacol"},{"key":"932_CR5","first-page":"731","volume":"67","author":"EG Mimnaugh","year":"1983","unstructured":"Mimnaugh EG, Trush MA, Gram TE (1983) Enhancement of rat heart microsomal lipid peroxidation following doxorubicin treatment in vivo. Cancer Treat Rep 67:731\u2013733","journal-title":"Cancer Treat Rep"},{"key":"932_CR6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0005-2728(97)00055-8","volume":"1321","author":"CM Palmeira","year":"1997","unstructured":"Palmeira CM, Serrano J, Kuehl DW et al (1997) Preferential oxidation of cardiac mitochondrial DNA following acute intoxication with doxorubicin. Biochim Biophys Acta 1321:101\u2013106","journal-title":"Biochim Biophys Acta"},{"key":"932_CR7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/taap.1993.1128","volume":"121","author":"LE Solem","year":"1993","unstructured":"Solem LE, Wallace KB (1993) Selective activation of the sodium-independent, cyclosporin A-sensitive calcium pore of cardiac mitochondria by doxorubicin. Toxicol Appl Pharmacol 121:50\u201357","journal-title":"Toxicol Appl Pharmacol"},{"key":"932_CR8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0005-2728(96)00041-2","volume":"1275","author":"P Bernardi","year":"1996","unstructured":"Bernardi P (1996) The permeability transition pore. Control points of a cyclosporin A-sensitive mitochondrial channel involved in cell death. Biochim Biophys Acta 1275:5\u20139","journal-title":"Biochim Biophys Acta"},{"issue":"Pt 2","key":"932_CR9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/bj3410233","volume":"341","author":"M Crompton","year":"1999","unstructured":"Crompton M (1999) The mitochondrial permeability transition pore and its role in cell death. Biochem J 341(Pt 2):233\u2013249","journal-title":"Biochem J"},{"key":"932_CR10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/15216540152846073","volume":"52","author":"F Di Lisa","year":"2001","unstructured":"Di Lisa F (2001) Mitochondrial contribution in the progression of cardiac ischemic injury. IUBMB Life 52:255\u2013261","journal-title":"IUBMB Life"},{"key":"932_CR11","first-page":"4592","volume":"62","author":"AC Childs","year":"2002","unstructured":"Childs AC, Phaneuf SL, Dirks AJ et al (2002) Doxorubicin treatment in vivo causes cytochrome c release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio. Cancer Res 62:4592\u20134598","journal-title":"Cancer Res"},{"key":"932_CR12","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0735-1097(02)02935-2","volume":"41","author":"S Yamanaka","year":"2003","unstructured":"Yamanaka S, Tatsumi T, Shiraishi J et al (2003) Amlodipine inhibits doxorubicin-induced apoptosis in neonatal rat cardiac myocytes. J Am Coll Cardiol 41:870\u2013878","journal-title":"J Am Coll Cardiol"},{"key":"932_CR13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/15216540500079093","volume":"57","author":"SM Cutts","year":"2005","unstructured":"Cutts SM, Nudelman A, Rephaeli A et al (2005) The power and potential of doxorubicin-DNA adducts. IUBMB Life 57:73\u201381","journal-title":"IUBMB Life"},{"key":"932_CR14","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1074\/jbc.271.10.5422","volume":"271","author":"SM Cutts","year":"1996","unstructured":"Cutts SM, Parsons PG, Sturm RA et al (1996) Adriamycin-induced DNA adducts inhibit the DNA interactions of transcription factors and RNA polymerase. J Biol Chem 271:5422\u20135429","journal-title":"J Biol Chem"},{"key":"932_CR15","doi-asserted-by":"crossref","first-page":"H1273","DOI":"10.1152\/ajpheart.00738.2005","volume":"291","author":"T L\u2019Ecuyer","year":"2006","unstructured":"L\u2019Ecuyer T, Sanjeev S, Thomas R et al (2006) DNA damage is an early event in doxorubicin-induced cardiac myocyte death. Am J Physiol Heart Circ Physiol 291:H1273\u2013H1280","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"932_CR16","doi-asserted-by":"crossref","first-page":"H2606","DOI":"10.1152\/ajpheart.01138.2005","volume":"290","author":"CC Chua","year":"2006","unstructured":"Chua CC, Liu X, Gao J et al (2006) Multiple actions of pifithrin-alpha on doxorubicin-induced apoptosis in rat myoblastic H9c2 cells. Am J Physiol Heart Circ Physiol 290:H2606\u2013H2613","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"932_CR17","doi-asserted-by":"crossref","first-page":"H933","DOI":"10.1152\/ajpheart.00759.2003","volume":"286","author":"X Liu","year":"2004","unstructured":"Liu X, Chua CC, Gao J et al (2004) Pifithrin-alpha protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice. Am J Physiol Heart Circ Physiol 286:H933\u2013H939","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"932_CR18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11010-005-5905-8","volume":"273","author":"Y Shizukuda","year":"2005","unstructured":"Shizukuda Y, Matoba S, Mian OY et al (2005) Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice. Mol Cell Biochem 273:25\u201332","journal-title":"Mol Cell Biochem"},{"key":"932_CR19","doi-asserted-by":"crossref","first-page":"16202","DOI":"10.1074\/jbc.275.21.16202","volume":"275","author":"ND Marchenko","year":"2000","unstructured":"Marchenko ND, Zaika A, Moll UM (2000) Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J Biol Chem 275:16202\u201316212","journal-title":"J Biol Chem"},{"key":"932_CR20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0014-5793(01)02284-0","volume":"493","author":"UM Moll","year":"2001","unstructured":"Moll UM, Zaika A (2001) Nuclear and mitochondrial apoptotic pathways of p53. FEBS Lett 493:65\u201369","journal-title":"FEBS Lett"},{"key":"932_CR21","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1042\/bst0290684","volume":"29","author":"M Schuler","year":"2001","unstructured":"Schuler M, Green DR (2001) Mechanisms of p53-dependent apoptosis. Biochem Soc Trans 29:684\u2013688","journal-title":"Biochem Soc Trans"},{"key":"932_CR22","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1089\/ars.2007.1632","volume":"9","author":"R Nithipongvanitch","year":"2007","unstructured":"Nithipongvanitch R, Ittarat W, Cole MP et al (2007) Mitochondrial and nuclear p53 localization in cardiomyocytes: redox modulation by doxorubicin (Adriamycin)? Antioxid Redox Signal 9:1001\u20131008","journal-title":"Antioxid Redox Signal"},{"key":"932_CR23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1369\/jhc.6A7146.2007","volume":"55","author":"R Nithipongvanitch","year":"2007","unstructured":"Nithipongvanitch R, Ittarat W, Velez JM et al (2007) Evidence for p53 as guardian of the cardiomyocyte mitochondrial genome following acute adriamycin treatment. J Histochem Cytochem 55:629\u2013639","journal-title":"J Histochem Cytochem"},{"key":"932_CR24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0014-4827(76)90447-X","volume":"98","author":"BW Kimes","year":"1976","unstructured":"Kimes BW, Brandt BL (1976) Properties of a clonal muscle cell line from rat heart. Exp Cell Res 98:367\u2013381","journal-title":"Exp Cell Res"},{"key":"932_CR25","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1006\/mgme.2001.3243","volume":"74","author":"T L\u2019Ecuyer","year":"2001","unstructured":"L\u2019Ecuyer T, Horenstein MS, Thomas R et al (2001) Anthracycline-induced cardiac injury using a cardiac cell line: potential for gene therapy studies. Mol Genet Metab 74:370\u2013379","journal-title":"Mol Genet Metab"},{"key":"932_CR26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/mpo.10052","volume":"38","author":"BM Frost","year":"2002","unstructured":"Frost BM, Eksborg S, Bjork O et al (2002) Pharmacokinetics of doxorubicin in children with acute lymphoblastic leukemia: multi-institutional collaborative study. Med Pediatr Oncol 38:329\u2013337","journal-title":"Med Pediatr Oncol"},{"key":"932_CR27","first-page":"59","volume":"36","author":"D Klein","year":"1995","unstructured":"Klein D, Kern RM, Sokol RZ (1995) A method for quantification and correction of proteins after transfer to immobilization membranes. Biochem Mol Biol Int 36:59\u201366","journal-title":"Biochem Mol Biol Int"},{"key":"932_CR28","doi-asserted-by":"crossref","first-page":"7826","DOI":"10.1016\/S0021-9258(18)83116-7","volume":"264","author":"KM Broekemeier","year":"1989","unstructured":"Broekemeier KM, Dempsey ME, Pfeiffer DR (1989) Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. J Biol Chem 264:7826\u20137830","journal-title":"J Biol Chem"},{"key":"932_CR29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10565-006-0140-y","volume":"23","author":"JM Berthiaume","year":"2007","unstructured":"Berthiaume JM, Wallace KB (2007) Adriamycin-induced oxidative mitochondrial cardiotoxicity. Cell Biol Toxicol 23:15\u201325","journal-title":"Cell Biol Toxicol"},{"key":"932_CR30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10565-007-9016-z","volume":"24","author":"A Hamza","year":"2008","unstructured":"Hamza A, Amin A, Daoud S (2008) The protective effect of a purified extract of Withania somnifera against doxorubicin-induced cardiac toxicity in rats. Cell Biol Toxicol 24:63\u201373","journal-title":"Cell Biol Toxicol"},{"key":"932_CR31","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jmgm.2006.09.005","volume":"26","author":"VG Box","year":"2007","unstructured":"Box VG (2007) The intercalation of DNA double helices with doxorubicin and nagalomycin. J Mol Graph Model 26:14\u201319","journal-title":"J Mol Graph Model"},{"key":"932_CR32","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1096\/fasebj.10.2.8641557","volume":"10","author":"WK Kaufmann","year":"1996","unstructured":"Kaufmann WK, Paules RS (1996) DNA damage and cell cycle checkpoints. FASEB J 10:238\u2013247","journal-title":"FASEB J"},{"key":"932_CR33","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF03167075","volume":"60","author":"M Gomez-Lazaro","year":"2004","unstructured":"Gomez-Lazaro M, Fernandez-Gomez FJ, Jordan J (2004) p53: twenty-five years understanding the mechanism of genome protection. J Physiol Biochem 60:287\u2013307","journal-title":"J Physiol Biochem"},{"key":"932_CR34","first-page":"1799","volume":"9","author":"T Miyashita","year":"1994","unstructured":"Miyashita T, Krajewski S, Krajewska M et al (1994) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799\u20131805","journal-title":"Oncogene"},{"key":"932_CR35","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0092-8674(95)90513-8","volume":"80","author":"T Miyashita","year":"1995","unstructured":"Miyashita T, Reed JC (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293\u2013299","journal-title":"Cell"},{"key":"932_CR36","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.bbabio.2006.04.011","volume":"1757","author":"NR Brady","year":"2006","unstructured":"Brady NR, Hamacher-Brady A, Gottlieb RA (2006) Proapoptotic BCL-2 family members and mitochondrial dysfunction during ischemia\/reperfusion injury, a study employing cardiac HL-1 cells and GFP biosensors. Biochim Biophys Acta 1757:667\u2013678","journal-title":"Biochim Biophys Acta"},{"key":"932_CR37","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1042\/bj20020805","volume":"367","author":"M Capano","year":"2002","unstructured":"Capano M, Crompton M (2002) Biphasic translocation of Bax to mitochondria. Biochem J 367:169\u2013178","journal-title":"Biochem J"},{"key":"932_CR38","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0092-8674(00)00167-7","volume":"103","author":"M Suzuki","year":"2000","unstructured":"Suzuki M, Youle RJ, Tjandra N (2000) Structure of Bax: coregulation of dimer formation and intracellular localization. Cell 103:645\u2013654","journal-title":"Cell"},{"key":"932_CR39","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/01.CIR.102.5.572","volume":"102","author":"T Nakamura","year":"2000","unstructured":"Nakamura T, Ueda Y, Juan Y et al (2000) Fas-mediated apoptosis in adriamycin-induced cardiomyopathy in rats: in vivo study. Circulation 102:572\u2013578","journal-title":"Circulation"},{"key":"932_CR40","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1385\/CT:5:3:257","volume":"5","author":"JM Berthiaume","year":"2005","unstructured":"Berthiaume JM, Oliveira PJ, Fariss MW et al (2005) Dietary vitamin E decreases doxorubicin-induced oxidative stress without preventing mitochondrial dysfunction. Cardiovasc Toxicol 5:257\u2013267","journal-title":"Cardiovasc Toxicol"},{"key":"932_CR41","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1742-7843.2005.pto960112.x","volume":"96","author":"SK Wattanapitayakul","year":"2005","unstructured":"Wattanapitayakul SK, Chularojmontri L, Herunsalee A et al (2005) Screening of antioxidants from medicinal plants for cardioprotective effect against doxorubicin toxicity. Basic Clin Pharmacol Toxicol 96:80\u201387","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"932_CR42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/10715769900300201","volume":"30","author":"R Albertini","year":"1999","unstructured":"Albertini R, Abuja PM (1999) Prooxidant and antioxidant properties of Trolox C, analogue of vitamin E, in oxidation of low-density lipoprotein. Free Radic Res 30:181\u2013188","journal-title":"Free Radic Res"},{"key":"932_CR43","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0300-483X(03)00158-6","volume":"189","author":"MW Fariss","year":"2003","unstructured":"Fariss MW, Zhang JG (2003) Vitamin E therapy in Parkinson\u2019s disease. Toxicology 189:129\u2013146","journal-title":"Toxicology"},{"key":"932_CR44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2121-8-11","volume":"8","author":"VA Sard\u00e3o","year":"2007","unstructured":"Sard\u00e3o VA, Oliveira PJ, Holy J et al (2007) Vital imaging of H9c2 myoblasts exposed to tert-butylhydroperoxide\u2014characterization of morphological features of cell death. BMC Cell Biol 8:11","journal-title":"BMC Cell Biol"},{"key":"932_CR45","first-page":"1","volume":"53","author":"SJ Flora","year":"2007","unstructured":"Flora SJ (2007) Role of free radicals and antioxidants in health and disease. Cell Mol Biol 53:1\u20132","journal-title":"Cell Mol Biol"},{"key":"932_CR46","first-page":"114","volume":"3","author":"GS Kelly","year":"1998","unstructured":"Kelly GS (1998) Clinical applications of N-acetylcysteine. Altern Med Rev 3:114\u2013127","journal-title":"Altern Med Rev"},{"key":"932_CR47","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.1016\/j.febslet.2006.05.072","volume":"580","author":"J Neuzil","year":"2006","unstructured":"Neuzil J, Wang XF, Dong LF et al (2006) Molecular mechanism of \u2018mitocan\u2019-induced apoptosis in cancer cells epitomizes the multiple roles of reactive oxygen species and Bcl-2 family proteins. FEBS Lett 580:5125\u20135129","journal-title":"FEBS Lett"},{"key":"932_CR48","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1042\/BST0340232","volume":"34","author":"AP Halestrap","year":"2006","unstructured":"Halestrap AP (2006) Calcium, mitochondria and reperfusion injury: a pore way to die. Biochem Soc Trans 34:232\u2013237","journal-title":"Biochem Soc Trans"},{"key":"932_CR49","first-page":"771","volume":"61","author":"S Zhou","year":"2001","unstructured":"Zhou S, Starkov A, Froberg MK et al (2001) Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin. Cancer Res 61:771\u2013777","journal-title":"Cancer Res"},{"key":"932_CR50","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.taap.2004.04.005","volume":"200","author":"PJ Oliveira","year":"2004","unstructured":"Oliveira PJ, Bjork JA, Santos MS et al (2004) Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity. Toxicol Appl Pharmacol 200:159\u2013168","journal-title":"Toxicol Appl Pharmacol"},{"key":"932_CR51","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM199610173351603","volume":"335","author":"J Narula","year":"1996","unstructured":"Narula J, Haider N, Virmani R et al (1996) Apoptosis in myocytes in end-stage heart failure. N Engl J Med 335:1182\u20131189","journal-title":"N Engl J Med"},{"key":"932_CR52","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1471-4914(03)00025-X","volume":"9","author":"PM Kang","year":"2003","unstructured":"Kang PM, Izumo S (2003) Apoptosis in heart: basic mechanisms and implications in cardiovascular diseases. Trends Mol Med 9:177\u2013182","journal-title":"Trends Mol Med"},{"key":"932_CR53","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1161\/01.RES.82.11.1111","volume":"82","author":"A Haunstetter","year":"1998","unstructured":"Haunstetter A, Izumo S (1998) Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ Res 82:1111\u20131129","journal-title":"Circ Res"},{"key":"932_CR54","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1023\/A:1015976430790","volume":"234\u2013235","author":"B Kalyanaraman","year":"2002","unstructured":"Kalyanaraman B, Joseph J, Kalivendi S et al (2002) Doxorubicin-induced apoptosis: implications in cardiotoxicity. Mol Cell Biochem 234\u2013235:119\u2013124","journal-title":"Mol Cell Biochem"},{"key":"932_CR55","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11010-005-2541-2","volume":"270","author":"HJ Youn","year":"2005","unstructured":"Youn HJ, Kim HS, Jeon MH et al (2005) Induction of caspase-independent apoptosis in H9c2 cardiomyocytes by adriamycin treatment. Mol Cell Biochem 270:13\u201319","journal-title":"Mol Cell Biochem"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-009-0932-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-009-0932-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-009-0932-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T23:03:34Z","timestamp":1633043014000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-009-0932-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,30]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["932"],"URL":"https:\/\/doi.org\/10.1007\/s00280-009-0932-x","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,30]]}}}